BiTE antibody MT#

Related by string. * BITE . BITES . Bites . bites . Bite : avoiding mosquito bites . tick bite . credit crunch bites . bug bites . snake bite / ANTIBODY . Antibody : antibody mediated rejection . Affinity Optimized Antibody . Crucell rabies monoclonal antibody . antibody fragments . humanized monoclonal antibody / MT# [002] . MT# [003] . MT# [001] : Mosler MT# . MediaTek MT# . Microtune MT# . adecatumumab MT# * *

Related by context. Frequent words. (Click for all words.) 62 Sym# 61 IND submission 61 Amrubicin 60 OXi# 60 randomized Phase III 60 phase 2a 59 Phase 2a clinical 59 INGN 59 CR# vcMMAE 59 angiogenesis inhibitor 58 PXD# 58 Pivotal Phase 58 pertuzumab 58 phase IIa 58 EORTC 58 humanized anti 58 Phase 1b 58 Phase IIa trial 58 AACR NCI EORTC 57 tanespimycin 57 Carfilzomib 57 metastatic hormone refractory 57 Phase Ib 57 Phase IIa clinical 57 registrational trial 57 Phase 2a trial 57 phase IIb 57 HER2 positive metastatic breast 56 GRN#L 56 dose escalation trial 56 Phase 2a 56 axitinib 56 Solid Tumors 56 Phase 2b study 56 imetelstat 56 HGS ETR1 56 seliciclib 56 registrational 56 palifosfamide 56 Pirfenidone 56 NSABP 56 AP# [003] 56 BiTE antibody 55 nab paclitaxel 55 Phase 1b trial 55 decitabine 55 IMC A# 55 metastatic renal cell carcinoma 55 Phase III Clinical Trial 55 mCRC 55 Phase Ia 55 drug conjugate 55 immune modulation 55 placebo controlled clinical 55 Gynecologic Oncology Group 55 Pivotal Phase III 55 relapsed refractory multiple myeloma 55 Clinical Trial Results 55 Phase 1b clinical 55 Avicena 55 Molecular Cancer 55 CYT# 54 orally bioavailable 54 ofatumumab 54 MOZOBIL 54 HCV protease inhibitor 54 Atiprimod 54 CA4P 54 Phase 1a 54 romidepsin 54 Bortezomib 54 bone metastasis 54 elesclomol 54 pharmacodynamic effects 54 Azedra 54 deforolimus 54 Small Molecule 54 IMGN# 54 Phase 2b clinical 54 SWOG 54 PF # [001] 54 VQD 54 induces apoptosis 54 Vilazodone 54 confirmatory Phase III 54 Immunogenicity 54 talabostat 54 ocrelizumab 54 MDV# 54 ISIS # 54 eltrombopag 54 tesmilifene 54 anticancer agent 54 antitumor activity 54 TOCOSOL Paclitaxel 54 vivo efficacy 54 GSK # 53 ponatinib 53 CoFactor 53 Phase III Trial 53 PRECiSE

Back to home page